Persistence has paid off for an Israeli businessman and a UK lawyer after the London Stock Exchange issued its first-ever listing guidelines for cannabis firms. Roby Zomer, Co-Founder and Managing Director of MGC Pharmaceuticals, says the pending change sets-up the UK for a huge influx of cannabis capital. Nick Davis, CEO of Memery Crystal, says it is a significant milestone in the rehabilitation of the cannabis plant and a result for UK cannabis patients. This time last year MGC and its lawyers Memery Crystal submitted its market listing prospectus to the LSE and, after a few weeks, they were given the go-ahead to proceed by the UK Listing Authority. However, in February this year, they learned the UK Financial Conduct Authority (FCA) had put the applications on hold.
Peter Mccusker, Cannabis Business Executive – Cannabis and Marijuana industry news, 12/23/2020 07:12:00